Contraindicated (one)pentobarbital will lessen the level or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with solid CYP3A4 inducers may result in lowered serum concentrations and loss of antimalarial efficacy Contraindicated (1